Promising Results for Anitocabtagene Autoleucel Therapy in Multiple Myeloma
Anitocabtagene autoleucel therapy showed promising results in patients with relapsed or refractory multiple myeloma....
Anitocabtagene autoleucel therapy showed promising results in patients with relapsed or refractory multiple myeloma....
Pelabresib plus ruxolitinib has shown efficacy in the treatment responses of patients with myelofibrosis....
Sovleplenib may offer QOL improvements for patients with primary immune thrombocytopenia....
Adding additional clinical and genetic information improved the performance of prognostic scores in secondary myelofibrosis, researchers in France report....
Blood cancer has emerged as a growing concern over the past decade, necessitating early diagnosis for timely and effective treatment. The present diagnostic method, which involves a battery ...
A panel of experts discusses the nuances of treating paroxysmal nocturnal hemoglobinuria in older patients, focusing on comorbidities and complications....
Acute myeloid leukemia (AML) is a type of blood cancer with diverse genetic variations and DNA methylation alterations. By studying the interaction of gene mutations, expression, and DNA met...
1. In this randomized controlled trial, CM313, an anti-CD38 monoclonal antibody therapy, was associated with rapid recovery of platelet counts among patients diagnosed with immune thrombocyt...
A panel of experts discuss the process of diagnosing paroxysmal nocturnal hemoglobinuria, as well as the impact of complement-inhibiting drugs on patients' QOL...
Personalized ddPCR monitoring of rare genetic alterations can help clinicians make timely treatment decisions for patients with leukemia, according to research....
Authors of a recent review provide updates on stem cell transplants for myelofibrosis, with an emphasis on managing graft versus host disease and relapse....
1. In this randomized controlled trial, among patients presenting with acute intracerebral hemorrhage (ICH) who had taken factor Xa inhibitors, andexanet resulted in less hematoma expansion ...
1. In this randomized controlled trial, among individuals with congenital thrombotic thrombocytopenic purpura (TTP), no patients in a prophylactic group that received recombinant ADAMTS13 ha...
1. A multivariate predictive model was developed to help determine when a bone marrow sample would help distinguish between patients with monoclonal gammopathy of undetermined significance (...
The following is a summary of "Role of coronary microvascular dysfunction in the pathogenesis of heart failure with preserved ejection fraction," published in the May 2024 issue of Cardiolog...
The following is a summary of "Testosterone Replacement Therapy in Klinefelter Syndrome—Follow-up Study Associating Hemostasis and RNA Expression," published in the April 2024 issue of End...
Despite readily available treatments for paroxysmal nocturnal hemoglobinuria, only around one-quarter of patients with the condition receive treatments....
One of the rarest of rare blood cancers, Erdheim-Chester disease presents diagnosis and treatment challenges....
Researchers tested if self-assessments could support the detection of smaller, but still critical, bleeding incidents in patients with immune thrombocytopenia. ...
Impact of perioperative low-molecular-weight heparin therapy on clinical events of elderly patients with prior coronary stents implanted > 12 months undergoing non-cardiac surgery: a rand...
The latest articles and insights from your colleagues in your specialty(ies) of choice.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.